The French Competition Authority carries out an inquiry in the area of prescription medicine distribution in private practices

Press Release published on the official website of the French Competition Authority.

The Autorité de la concurrence is submitting to public consultation an initial assessment in which it has identified several potential sticking points* Medicinal products are the second-largest health-expenditure item in France, totalling around 35 billion euros in 2011, putting France fifth in the world in terms of average individual consumption. This is why, given the economic weight of this sector of activity, and acknowledging several contentious medicine-related issues as well as the increase in requests for opinions from public authorities on the development of the legislative and regulatory framework for the distribution of medicines, in February 2013 the Autorité de la concurrence decided to embark on a sector enquiry to investigate competitive operation within the sector and

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

French Competition Authority, The French Competition Authority carries out an inquiry in the area of prescription medicine distribution in private practices, 10 July 2013, e-Competitions Bulletin July 2013, Art. N° 58157

Visites 253

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues